🇺🇸 FDA
Patent

US 8236815

Ion channel modulators and methods of uses

granted A61KA61K31/506A61P

Quick answer

US patent 8236815 (Ion channel modulators and methods of uses) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/506, A61P, A61P1/04, A61P19/02